Impact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices

Heart Rhythm

Volumn 12, Issue 1, 2015, Pages 52-59

  Afzal, Muhammad R ^a   Kanmanthareddy, Arun ^a   Earnest, Matthew ^a   Reddy, Madhu ^a   Atkins, Donita ^a   Bommana, Sudharani ^a   Bartus, Krystof ^b   Rasekh, Abdi ^c   Han, Fred ^d   Badhwar, Nitish ^e   Cheng, Jie ^d,f   Dibiase, Luigi ^g   Ellis, Christopher R ^h   Dawn, Buddhadeb ^a   Natale, Andrea ^g   Lee, Randall J ^e   Lakkireddy, Dhanunjaya ^a  

^a UNIVERSITY OF KANSAS HOSPITAL   (United States)

^b Regional Centre for Diagnosis and Treatment of Viral Hepatitis and Hepatology   (Poland)

^c TEXAS HEART INSTITUTE   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e UNIVERSITY OF SAN FRANCISCO   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g Texas Cardiac Arrhythmia Institute   (United States)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Atrial fibrillation; Left atrial appendage; Pericarditis; Suture exclusion

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT;

AGED; ARTICLE; BLEEDING; CARDIAC IMPLANT; CARDIAC IMPLANTABLE ELECTRONIC DEVICE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR SURGICAL EQUIPMENT; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART CATHETER; HUMAN; LARIAT DEVICE; LEFT ATRIAL APPENDAGE; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CLINICAL TRIAL; DEVICES; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LIGATION; MIDDLE AGED; PERICARDIUM; SURGERY; SUTURE; TREATMENT OUTCOME;

AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIGATION; MALE; MIDDLE AGED; PERICARDIUM; PROSPECTIVE STUDIES; SUTURES; TREATMENT OUTCOME;

EID: 84920640565     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.09.053     Document Type: Article

References (22)

1. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 2013.
2. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996;61:755-759.
3. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P, Investigators PA. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534-542.
4. Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, Halperin JL, Holmes D, Investigators PA. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) trial. Circulation 2013;127:720-729.
5. Cabrera JA, Ho SY, Climent V, Sanchez-Quintana D. The architecture of the left lateral atrial wall: a particular anatomic region with implications for ablation of atrial fibrillation. Eur Heart J 2008;29:356-362.
6. Ho SY, Sanchez-Quintana D, Cabrera JA, Anderson RH. Anatomy of the left atrium: implications for radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol 1999;10:1525-1533.
7. Benussi S, Mazzone P, Maccabelli G, Vergara P, Grimaldi A, Pozzoli A, Spagnolo P, Alfieri O, Della Bella P. Thoracoscopic appendage exclusion with an AtriClip device as a solo treatment for focal atrial tachycardia. Circulation 2011;123:1575-1578.
8. Yang Q, Ma J, Zhang S, Hu JQ, Liao ZL. Focal atrial tachycardia originating from the distal portion of the left atrial appendage: characteristics and long-term outcomes of radiofrequency ablation. Europace 2012;14:254-260.
9. Hocini M, Shah AJ, Nault I, et al. Localized reentry within the left atrial appendage: arrhythmogenic role in patients undergoing ablation of persistent atrial fibrillation. Heart Rhythm 2011;8:1853-1861.
10. Di Biase L, Burkhardt JD, Mohanty P, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation 2010;122:109-126.
11. Yamada T, McElderry HT, Alison JS, Kay GN. Focal atrial tachycardia originating from the epicardial left atrial appendage. Heart Rhythm 2008;5:766-767.
12. Bartus K, Bednarek J, Myc J, Kapelak B, Sadowski J, Lelakowski J, Yakubov SJ, Lee RJ. Feasibility of closed-chest ligation of the left atrial appendage in humans. Heart Rhythm 2011;8:188-193.
13. Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, Mishkel G, Almany S, Holmes DR. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2007;49:1490-1495.
14. Bartus K, Morelli RL, Szczepanski W, Kapelak B, Sadowski J, Lee RJ. Anatomic analysis of the left atrial appendage after closure with the LARIAT device. Circ Arrhythmia Electrophysiol 2014;7:764-767.
15. Starck CT, Steffel J, Emmert MY, Plass A, Mahapatra S, Falk V, Salzberg SP. Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage. Interact Cardiovasc Ther 2012;15:416-418.
16. Han FT, Bartus K, Lakkireddy D, Rojas F, Bednarek J, Kapelak B, Bartus M, Sadowski J, Badhwar N, Earnest M, Valderrabano M, Lee RJ. The effects of LAA ligation on LAA electrical activity. Heart Rhythm 2014;11:864-870.
17. Bartus K, Han FT, Bednarek J, Myc J, Kapelak B, Sadowski J, Lelakowski J, Bartus S, Yakubov SJ, Lee RJ. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation initial clinical experience. J Am Coll Cardiol 2013;62:108-118.
18. Price MJ, Gibson DN, Yakubov SJ, et al. Early safety and ef ficacy of percutaneous left atrial appendage suture ligation: results from the U.S. Transcatheter LAA Ligation Consortium. J Am Coll Cardiol 2014;64:565-572.
19. Yamada T, McElderry HT, Allison JS, Kay GN. Focal atrial tachycardia originating from the epicardial left atrial appendage. Heart Rhythm 2008;5:766-767.
20. Lin YJ, Tsao HM, Chang SL, Lo LW, Hu YF, Chang CJ, Tsai WC, Suenari K, Huang SY, Chang HY, Wu TJ, Chen SA. Role of high dominant frequency sites in nonparoxysmal atrial fibrillation patients: insights from high-density frequency and fractionation mapping. Heart Rhythm 2010;7:1255-1262.
21. Sanders P, Berenfeld O, Hocini MZ, et al. Spectral analysis identi fies sites of high-frequency activity maintaining atrial fi brillation in humans. Circulation 2005;112:789-797.
22. Reddy M, Di Biase L, Vallakati A, Swarup V, Umbarger L, Bakdunes W, Bommana S, Atkins D, Natale A, Lakkireddy D. Predictors of severe left atrial scarring in patients with paroxysmal atrial fibrillation: unveiling a new syndrome of atriomyopathy. Heart Rhythm 2013;10:S126.